Supply Chain Truce In COVID-19: Will It Carry Over When Rx Price Debate Resumes?

 
• By Michael McCaughan

Manufacturers, insurers, pharmacies and PBMs are united in trying to assure ongoing access to medicines amid the COVID-19 outbreak. Will making common cause in a national emergency mean a more cooperative approach to addressing US drug pricing concerns when normalcy returns?

White Flag
Time To Put Down Their Weapons

More from Pricing Debate

More from Market Access